Emily Curran

STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia

Emily Curran, Xiufen Chen, Leticia Corrales et al. · Cell Reports · 2016 · 175 citations · Full text

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

Nitin Jain, Emily Curran, Neil M. Iyengar et al. · Clinical Cancer Research · 2013 · 111 citations · Full text

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia

Amy Wang, Howard Weiner, Margaret Green et al. · Journal of Hematology & Oncology · 2018 · 67 citations · Full text

Gender affects survival for medulloblastoma only in older children and adults: A study from the surveillance epidemiology and end results registry

Emily Curran, Kristin L. Sainani, Gem M. Le et al. · Pediatric Blood & Cancer · 2008 · 50 citations · Full text

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab

Talha Badar, Anikó Szabó, Anjali S. Advani et al. · Blood Advances · 2020 · 44 citations · Full text